VASCULAR CALCIFICATION IN CHRONIC KIDNEY DISEASE: A CLINICAL REVIEW

被引:15
作者
Eddington, Helen [1 ]
Sinha, Smeeta [1 ]
Kalra, Philip A. [1 ]
机构
[1] Salford Royal Fdn NHS Trust, Vasc Res Grp, Salford M6 8HD, Lancs, England
关键词
Bone disease; Cardiovascular; Chronic kidney disease; Haemodialysis;
D O I
10.1111/j.1755-6686.2009.00059.x
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Vascular calcification, which is associated with arterial stiffness, is now known to be an important predictor of cardiovascular and all-cause mortality in patients with renal disease. This calcification starts developing in the early stages of chronic kidney disease (CKD) and is present in over 50% of patients at the time of dialysis commencement. Once calcification is present it continues to progress, though some medications have been shown to slow this progression. Vascular calcification and bone abnormalities are now both encompassed by the term of CKD-mineral bone disorder and are thought to be part of the same disease process in CKD. Vascular calcification and arterial stiffness have been extensively researched in the renal population and many factors are known to be associated with their presence and progression. This calcification is an important factor to be considered in the management of the renal patient but there are different methods available for its measurement. These details will be discussed further in this review along with evidence available for management of this important complication of renal disease.
引用
收藏
页码:45 / 50
页数:6
相关论文
共 35 条
[1]   A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients [J].
Adragao, T ;
Pires, A ;
Lucas, C ;
Birne, R ;
Magalhaes, L ;
Gonçalves, M ;
Negrao, AP .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (06) :1480-1488
[2]   Impact of aortic stiffness on survival in end-stage renal disease [J].
Blacher, J ;
Guerin, AP ;
Pannier, B ;
Marchais, SJ ;
Safar, ME ;
London, GM .
CIRCULATION, 1999, 99 (18) :2434-2439
[3]   Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients [J].
Block, G. A. ;
Raggi, P. ;
Bellasi, A. ;
Kooienga, L. ;
Spiegel, D. M. .
KIDNEY INTERNATIONAL, 2007, 71 (05) :438-441
[4]   Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis [J].
Block, GA ;
Spiegel, DM ;
Ehrlich, J ;
Mehta, R ;
Lindbergh, J ;
Dreisbach, A ;
Raggi, P .
KIDNEY INTERNATIONAL, 2005, 68 (04) :1815-1824
[5]   Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism [J].
Block, Geoffrey A. ;
Zeig, Steven ;
Sugihara, Jared ;
Chertow, Glenn M. ;
Chi, Eric M. ;
Turner, Stewart A. ;
Bushinsky, David A. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (07) :2311-2318
[6]   Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients [J].
Braun, J ;
Oldendorf, M ;
Moshage, W ;
Heidler, R ;
Zeitler, E ;
Luft, FC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (03) :394-401
[7]   Differential effects of 19-nor-1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 on intestinal calcium and phosphate transport [J].
Brown, AJ ;
Finch, J ;
Slatopolsky, E .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2002, 139 (05) :279-284
[8]   Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients [J].
Chertow, GM ;
Burke, SK ;
Raggi, P .
KIDNEY INTERNATIONAL, 2002, 62 (01) :245-252
[9]   Arterial stiffness in renal patients: An update [J].
Covic, A ;
Gusbeth-Tatomir, P ;
Goldsmith, DJA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (06) :965-977
[10]   Differential effects of acute administration of 19-nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patients [J].
Coyne, DW ;
Grieff, M ;
Ahya, SN ;
Giles, K ;
Norwood, K ;
Slatopolsky, E .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (06) :1283-1288